Exposure‐Response (Efficacy) Analysis of Daclatasvir and Asunaprevir in Japanese Patients With Hepatitis C Virus Infection

The treatment of hepatitis C virus (HCV) infection has been revolutionized by the development of all‐oral combination regimens of direct‐acting antiviral agents. The current analysis characterized the relationship between exposures of daclatasvir (DCV; tablets) and asunaprevir (ASV; capsules) and su...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Takayo, Osawa, Mayu, Imai, Yasuhiko, Ishikawa, Hiroki, Garimella, Tushar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Exposure‐Response
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175176/
https://www.ncbi.nlm.nih.gov/pubmed/30063245
http://dx.doi.org/10.1002/jcph.1262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175176/
https://www.ncbi.nlm.nih.gov/pubmed/30063245
http://dx.doi.org/10.1002/jcph.1262

Ejemplares similares